128 related articles for article (PubMed ID: 7449299)
1. beta-Adrenoreceptor-blocking agents and the blood-brain barrier.
Cruickshank JM; Neil-Dwyer G; Cameron MM; McAinsh J
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():453s-455s. PubMed ID: 7449299
[TBL] [Abstract][Full Text] [Related]
2. Beta-adrenoceptor blockers and the blood-brian barrier.
Neil-Dwyer G; Bartlett J; McAinsh J; Cruickshank JM
Br J Clin Pharmacol; 1981 Jun; 11(6):549-53. PubMed ID: 6115665
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system kinetics of atenolol and metoprolol in the dog during long term treatment.
Abrahamsson T; Lignell E; Mikulski A; Olovson SG; Regårdh CG
Drug Metab Dispos; 1989; 17(1):82-6. PubMed ID: 2566475
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: evidence for central actions of beta-adrenoceptor antagonists.
Taylor EA; Jefferson D; Carroll JD; Turner P
Br J Clin Pharmacol; 1981 Oct; 12(4):549-59. PubMed ID: 6117308
[TBL] [Abstract][Full Text] [Related]
5. Receptor occupancy in lumbar CSF as a measure of the antagonist activity of atenolol, metoprolol and propranolol in the CNS.
Kaila T; Marttila R
Br J Clin Pharmacol; 1993 May; 35(5):507-15. PubMed ID: 8099803
[TBL] [Abstract][Full Text] [Related]
6. Comparison between the acute hemodynamic effects and brain penetration of atenolol and metoprolol.
van Zwieten PA; Timmermans PB
J Cardiovasc Pharmacol; 1979; 1(1):85-96. PubMed ID: 94385
[TBL] [Abstract][Full Text] [Related]
7. Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine.
Kirch W; Spahn H; Köhler H; Ohnhaus EE; Mutschler E
Klin Wochenschr; 1982 Nov; 60(22):1401-7. PubMed ID: 7176462
[TBL] [Abstract][Full Text] [Related]
8. High-performance liquid chromatographic method for the quantitative analysis of the aryloxypropanolamines propranolol, metoprolol and atenolol in plasma and tissue.
Winkler H; Ried W; Lemmer B
J Chromatogr; 1982 Mar; 228():223-34. PubMed ID: 7076746
[TBL] [Abstract][Full Text] [Related]
9. Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.
Hallengren B; Nilsson OR; Karlberg BE; Melander A; Tegler L; Wåhlin-Boll E
Eur J Clin Pharmacol; 1982; 21(5):379-84. PubMed ID: 7075643
[TBL] [Abstract][Full Text] [Related]
10. Central nervous system side-effects with hydrophilic and lipophilic beta-blockers.
Westerlund A
Eur J Clin Pharmacol; 1985; 28 Suppl():73-6. PubMed ID: 2865153
[TBL] [Abstract][Full Text] [Related]
11. Beta-blocker brain concentrations in man.
Cruickshank JM; Neil-Dwyer G
Eur J Clin Pharmacol; 1985; 28 Suppl():21-3. PubMed ID: 2865144
[TBL] [Abstract][Full Text] [Related]
12. Interaction of cimetidine with metoprolol, propranolol, or atenolol.
Kirch W; Köhler H; Spahn H; Mutschler E
Lancet; 1981 Sep; 2(8245):531-2. PubMed ID: 6115283
[No Abstract] [Full Text] [Related]
13. Determination of the new beta-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography.
Bühring KU; Garbe A
J Chromatogr; 1986 Oct; 382():215-24. PubMed ID: 2878004
[TBL] [Abstract][Full Text] [Related]
14. The clinical importance of lipid solubility in beta blockers.
Neil-Dwyer G
Aviat Space Environ Med; 1981 Nov; 52(11 Pt 2):S19-22. PubMed ID: 6118118
[TBL] [Abstract][Full Text] [Related]
15. Effect of diltiazem on the pharmacokinetics of propranolol, metoprolol and atenolol.
Tateishi T; Nakashima H; Shitou T; Kumagai Y; Ohashi K; Hosoda S; Ebihara A
Eur J Clin Pharmacol; 1989; 36(1):67-70. PubMed ID: 2917591
[TBL] [Abstract][Full Text] [Related]
16. Effects of metoprolol, alone and in combination with lidocaine, on ventricular fibrillation threshold: comparison with atenolol, propranolol, and pindolol.
Coram WM; Olson RW; Beil ME; Cabot CF; Weiss GB
J Cardiovasc Pharmacol; 1987 May; 9(5):611-21. PubMed ID: 2439844
[TBL] [Abstract][Full Text] [Related]
17. Thin-layer chromatographic analysis of some beta-blocking drugs in plasma.
Witek A; Przyborowski L
Acta Pol Pharm; 1997; 54(3):183-6. PubMed ID: 9511444
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol.
Regårdh CG; Johnsson G; Jordö L; Lungborg P; Persson BA; Rönn O
J Cardiovasc Pharmacol; 1980; 2(6):715-23. PubMed ID: 6160322
[TBL] [Abstract][Full Text] [Related]
19. Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
Gangji D; Juvent M; Niset G; Wathieu M; Degreve M; Bellens R; Poortmans J; Degre S; Fitzsimons TJ; Herchuelz A
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):29S-35S. PubMed ID: 6146337
[TBL] [Abstract][Full Text] [Related]
20. Quantification of Bisoprolol and Metoprolol in Simultaneous Human Serum and Cerebrospinal Fluid Samples.
Sigaroudi A; Kinzig M; Wahl O; Stelzer C; Schroeter M; Fuhr U; Holzgrabe U; Sörgel F
Pharmacology; 2018; 101(1-2):29-34. PubMed ID: 28930747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
